The push for innovation drives both scientific discovery and transformative business strategies. Whether you’re an industry leader or a new market entrant, you want creative thinking and a clear path to future growth – and that’s exactly what our dedicated lawyers deliver.
Innovators and investors across the life sciences sector rely on our multidisciplinary team for help in tackling highly complex transactions and legal issues. From biotech firms to medical device manufacturers, and from private equity investors to pharmaceutical giants, we work with all industry players to help navigate the daunting business challenges that arise where innovation and regulation intersect.
At any stage in the life cycle, from the creation of a promising new therapy through commercialization, product licensing and regulatory compliance, and whether negotiating strategic alliances or a complex global merger, we have the sector expertise and experience to develop strategies and solutions that work.
Fédération des médecins spécialistes du Québec, 2020
Acted for the Fédération des médecins spécialistes du Québec (FMSQ) in defence of a class action relating to fees charged to patients. The group representatives allege that the FMSQ prompted its members to charge certain fees to insured patients in violation of the Health Insurance Act.
Apotex International Inc., 2020
Acted as lead transaction and tax counsel to Apotex Inc. and ApoPharma USA Inc. on the sale of the ApoPharma business, including the global rights to Deferiprone, an iron chelator used to treat iron overload conditions resulting from blood transfusions, to Chiesi Farmaceutici S.p.A.